Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TAZPEN FOR INJECTION 4.5g/VIAL

Approval Number

SIN13758P

Drug Name

TAZPEN FOR INJECTION 4.5g/VIAL

Product Name

TAZPEN FOR INJECTION 4.5g/VIAL

Approval Date

January 26, 2010

Registrant

TRINITY PHARMACEUTICALS & FOOD PTE. LTD.

Licence Holder

TRINITY PHARMACEUTICALS & FOOD PTE. LTD.

Regulatory Information

Registrant

TRINITY PHARMACEUTICALS & FOOD PTE. LTD.

Licence Holder

TRINITY PHARMACEUTICALS & FOOD PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

J01CR05

ATC Item Name

piperacillin and beta-lactamase inhibitor

Manufacturer Information

Pharmaceutical Manufacturer

TRINITY PHARMACEUTICALS & FOOD PTE. LTD.

Manufacturers

Qilu Pharmaceutical Co. Ltd. (Intermediate drug product)

Steriscience Specialties Private Limited Beta Lactam Division

Active Ingredients

Ingredient Name

Tazobactam sodium equivalent to Tazobactam

Strength

0.50g

Drug MonographTazobactam

Ingredient Name

Piperacillin sodium equivalent to Piperacillin

Strength

4.0g

Drug MonographPiperacillin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy